A Qualitative Study on Perspectives of Parkinson’s Disease Medications: Insights from Patient Focus Groups

IF 2 3区医学 Q2 MEDICINE, GENERAL & INTERNAL

Patient preference and adherence Pub Date : 2024-09-18 DOI:10.2147/ppa.s473991

Kristin Richards, Sneha Mantri, Carolyn M Brown, Michael Johnsrud, Steve Arcona, Rahul Sasané

{"title":"A Qualitative Study on Perspectives of Parkinson’s Disease Medications: Insights from Patient Focus Groups","authors":"Kristin Richards, Sneha Mantri, Carolyn M Brown, Michael Johnsrud, Steve Arcona, Rahul Sasané","doi":"10.2147/ppa.s473991","DOIUrl":null,"url":null,"abstract":"Purpose: Medication is an important component of the management of Parkinson’s disease (PD), yet few studies investigate factors that inform medication decision-making from the perspective of those who use these therapies. This qualitative study aimed to better understand the medication experiences and perspectives of people with PD (PwPD). Patients and Methods: Thirty-two PwPD recruited from five large movement disorder clinics from five US states participated in 1-hour on-line focus groups in 2022. Thematic analysis was used to analyze the data. Results: Four primary themes (subthemes in parentheses) emerged concerning PD medications: (1) medication effectiveness (uncertainty, inconsistent effects, adjusting expectations); (2) medication burden (morning doses, timing challenges, constant reminder); (3) side effects (toleration, treatment, confusion with disease symptoms); and (4) preferences/requests (important attributes, therapy advancement). Conclusion: This study identified four core dimensions associated with PD medications from the perspective of PwPD. Results indicate the need for enhanced communication between providers and patients regarding PD medication to reduce the uncertainties and burden associated with PD medication regimens and promote better health outcomes for PwPD. Keywords: Parkinson’s disease, medication, patient perspective, patient experience ","PeriodicalId":19972,"journal":{"name":"Patient preference and adherence","volume":"45 1","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Patient preference and adherence","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/ppa.s473991","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: Medication is an important component of the management of Parkinson’s disease (PD), yet few studies investigate factors that inform medication decision-making from the perspective of those who use these therapies. This qualitative study aimed to better understand the medication experiences and perspectives of people with PD (PwPD).
Patients and Methods: Thirty-two PwPD recruited from five large movement disorder clinics from five US states participated in 1-hour on-line focus groups in 2022. Thematic analysis was used to analyze the data.
Results: Four primary themes (subthemes in parentheses) emerged concerning PD medications: (1) medication effectiveness (uncertainty, inconsistent effects, adjusting expectations); (2) medication burden (morning doses, timing challenges, constant reminder); (3) side effects (toleration, treatment, confusion with disease symptoms); and (4) preferences/requests (important attributes, therapy advancement).
Conclusion: This study identified four core dimensions associated with PD medications from the perspective of PwPD. Results indicate the need for enhanced communication between providers and patients regarding PD medication to reduce the uncertainties and burden associated with PD medication regimens and promote better health outcomes for PwPD.

Keywords: Parkinson’s disease, medication, patient perspective, patient experience

查看原文本刊更多论文

帕金森病药物观点定性研究：来自患者焦点小组的见解

目的：药物治疗是帕金森病（PD）治疗的重要组成部分，但很少有研究从使用这些疗法的患者的角度来调查影响药物治疗决策的因素。这项定性研究旨在更好地了解帕金森病患者（PwPD）的用药经历和观点：2022 年，从美国五个州的五家大型运动障碍诊所招募的 32 名帕金森病患者参加了一个小时的在线焦点小组。采用主题分析法对数据进行分析：出现了与帕金森氏症药物治疗相关的四个主要主题（括号内为次主题）：（1）药物治疗效果（不确定性、效果不一致、调整期望值）；（2）药物治疗负担（晨起服药、时间挑战、不断提醒）；（3）副作用（耐受性、治疗、与疾病症状混淆）；以及（4）偏好/要求（重要属性、治疗进展）：本研究从残疾人的角度确定了与帕金森病药物治疗相关的四个核心维度。研究结果表明，有必要加强医疗服务提供者与患者之间在帕金森病药物治疗方面的沟通，以减少帕金森病药物治疗方案的不确定性和负担，促进帕金森病患者获得更好的健康结果：帕金森病、药物治疗、患者观点、患者体验

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Patient preference and adherence MEDICINE, GENERAL & INTERNAL-

CiteScore

3.60

自引率

4.50%

发文量

354

审稿时长

6-12 weeks

期刊介绍： Patient Preference and Adherence is an international, peer reviewed, open access journal that focuses on the growing importance of patient preference and adherence throughout the therapeutic continuum. The journal is characterized by the rapid reporting of reviews, original research, modeling and clinical studies across all therapeutic areas. Patient satisfaction, acceptability, quality of life, compliance, persistence and their role in developing new therapeutic modalities and compounds to optimize clinical outcomes for existing disease states are major areas of interest for the journal. As of 1st April 2019, Patient Preference and Adherence will no longer consider meta-analyses for publication.